Clinical Trials Logo

Migraine Disorders clinical trials

View clinical trials related to Migraine Disorders.

Filter by:

NCT ID: NCT05418218 Recruiting - Fibromyalgia Clinical Trials

International Headache Registry Study

IHRS
Start date: July 12, 2021
Phase:
Study type: Observational [Patient Registry]

In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.

NCT ID: NCT05416476 Recruiting - Clinical trials for Migraine Without Aura

Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine

ATEM
Start date: October 30, 2023
Phase: Phase 3
Study type: Interventional

In this study,288 adult migraine patients aged 18-65 years (diagnosed with migraine without aura and/or migraine with aura, with at least a 1-year history)will be collected to evaluate the efficacy, safety and tolerability of Anisodine Hydrobromide in preventing migraine attacks in episodic migraine in adults.

NCT ID: NCT05415020 Recruiting - Migraine Clinical Trials

Determining the Utility of a Behavioral Intervention in Chronic Migraine

RLB
Start date: June 29, 2022
Phase: N/A
Study type: Interventional

This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.

NCT ID: NCT05411978 Recruiting - Migraine Clinical Trials

Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients

Start date: May 9, 2022
Phase: Phase 4
Study type: Interventional

This is a multi-center, prospective, double-blind randomized controlled trial on a sample of patients with migraine. Subjects will only be enrolled when a physician or research assistant who is familiar with the study protocol is available to enroll patients. Written, informed consent will be obtained from each patient. Consent will include a discussion of the risks and benefits.

NCT ID: NCT05407402 Not yet recruiting - Pain, Head Clinical Trials

Laughter Yoga on Pain and Comfort in Individuals Diagnosed With Migraine

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

In individuals diagnosed with migraine, laughter yoga will be performed for 45 minutes, 3 times a week for 1 month. the other application group will watch funny videos for 45 minutes, 3 times a week for 1 month.

NCT ID: NCT05403229 Recruiting - Clinical trials for Sudden Sensorineural Hearing Loss

The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss

Start date: October 17, 2022
Phase: Phase 2
Study type: Interventional

Migraine and sudden sensorineural hearing loss(SSNHL) are two related disorders. A systemic steroid is usually used to treat SSNHL but the role of migraine prophylaxis medication remained unknown. Mehdi Abouzari et al. found a better improvement when combining topiramate and nortriptyline with steroids in a retrospective study. However, a prospective study with randomization is needed to elucidate the efficacy of these agents. This is a clinical study using medication approved and currently prescribed in the clinic. The included patients were those who came to the clinic and were diagnosed with SSNHL within 14 days of onset. Those patients were asked whether they agreed to participate in this clinical trial. Patients who were diagnosed with SSNHL but were later found to be other diseases such as Meniere's disease and cerebellopontine angle will be excluded from this study. The involved patients were randomized divided into two groups. Both groups received systemic steroids with/without intratympanic steroids. The experimental group receives additional oral topiramate for 6 weeks. Follow-up time is at least 3 months. This study is multi-center. Location of the study is performed at Chang gung memorial hospital Linkou branch, Taipei branch, Taoyuan branch, and New Taipei Municipal Tucheng Hospital.

NCT ID: NCT05399485 Active, not recruiting - Migraine Clinical Trials

Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the prevention of migraine.

NCT ID: NCT05399459 Completed - Migraine Clinical Trials

Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

This study is being conducted to determine the appropriate dose of rimegepant in Japanese subjects, as well as to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the acute treatment of migraine.

NCT ID: NCT05396482 Enrolling by invitation - Vestibular Migraine Clinical Trials

Assesment of Hearing in Patients With Vestibular Migra

Start date: October 1, 2020
Phase:
Study type: Observational

Evaluation of hearing in patients with vestibular migraine

NCT ID: NCT05382832 Not yet recruiting - Migraine Clinical Trials

Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial

BTX/SCS/TMig
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The clinical trial is focused on the treatment of selected patients with a migraine after implantation of spinal cord stimulator (SCS) based on previous neurological examination. Patients will be randomized and divided into two groups. According to randomization patients will receive saline or botox into the epidural space. The efficacy of treatment will be compared and estimated in both groups during different SCS settings. Data will be collected in pre-set time frames.